1Winkles JA. The TWEAK-Fnl4 cytoklne-receptor axis., discovery, biology and therapeutic targeting[J]. Nat Rev Drug Discov, 2008, 7(5): 411- 425.
2Wiley SR, Cassiano L, Lofton T, et al. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis[J]. Immunity, 2001, 15(5): 837-846.
3Brown SA, Hanscom HN, Vu H, et al. TWEAK binding to the Fn14 cysteine rich domain depends on charged residues located in both the A1 and D2 modules[J]. Bioehem J, 2006, 397(2) : 297- 304.
4Brown SA, Richards CM, Hanscom HN, et al. The Fnl4 cytoplasmic tail binds tumour-necrosis-factor-receptor- associated factors 1, 2, 3 and 5 and mediates nuclear factor- kappaB activation[J]. Biochem J, 2003, 371(2) :395-403.
5Chicheportiche Y, Bourdon PR, Xu H, et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis[J]. J Biol Chem, 1997, 272(51) 32401-32410.
6Munoz-Garcia B, Martin-Ventura JL, Martinez E, et al. Fnl4 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin [J]. Stroke, 2006, 37(8): 2044-2053.
7Weinberg JM. TWEAK-Fn14 as a mediator of acute kidney injury[J]. KidneyInt, 2011, 79(2): 151-153.
8Polek TC, Talpaz M, Darnay BG, et al. TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor [J]. J Biol Chem, 2003, 278 (34): 32317-32323.
9Moreno JA, Munoz-Garcia B, Martin-Ventura JL, et al. The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis [J]. Atherosclerosis, 2009, 207(1): 103-110.
10Abraham NG, Drummond G. CD163-Mediated hemoglobin- heine uptake activates macropbage HO-1, providing an antiinflammatory function [ J ]. Circ Res, 2006, 99 (9) :911 -914.
5Sastre C,Fernández-Laso V,Madrigal-Matute J,et al. Geneticdeletion or TWEAK blocking antibody administration reduceatherosclerosis and enhance plaque stability in mice[J]. Journal ofCellular & Molecular Medicine,2014,22(5):34-7.
6Moreno JA,Ortegagómez A,Delbosc S,et al. In vitro and in vivoevidence for the role of elastase shedding of CD163 in humanatherothrombosis[J]. European Heart Journal,2012,25(5):46-9.
7Masood A,Jafar S S,Akram Z. Serum high sensitivity C-reactiveprotein levels and the severity of coronary atherosclerosis assessedby angiographic gensini score[J]. Journal of the Pakistan MedicalAssociation,2011,61(4):325-7.
